scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1022721494 |
P356 | DOI | 10.1385/EP:14:2:123 |
P698 | PubMed publication ID | 12858002 |
P2093 | author name string | Hiroshi Takami | |
P2860 | cites work | Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products | Q28264638 |
Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing | Q28266416 | ||
Mutations of the RET proto-oncogene in the multiple endocrine neoplasia type 2 syndromes, related sporadic tumours, and hirschsprung disease | Q28305753 | ||
Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B | Q28776010 | ||
Importance of early screening and prophylactic thyroidectomy in asymptomatic nonindex RET germline carriers | Q30320962 | ||
Genotype-phenotype correlations in hereditary medullary thyroid carcinoma: oncological features and biochemical properties | Q30321003 | ||
Prophylactic thyroidectomy in 75 children and adolescents with hereditary medullary thyroid carcinoma: German and Austrian experience. | Q30321277 | ||
Normal thyroid pathology in patients undergoing thyroidectomy for finding a RETgene germline mutation: a report of three cases and review of the literature | Q33544569 | ||
Guidelines for diagnosis and therapy of MEN type 1 and type 2. | Q34104591 | ||
Multiple endocrine neoplasia type 2: molecular aspects | Q34302453 | ||
Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. | Q34334980 | ||
Advances in the diagnosis and treatment of medullary thyroid carcinoma. | Q39462141 | ||
C-cell disease of the thyroid gland in multiple endocrine neoplasia, type 2B | Q39824843 | ||
Preoperative calcitonin levels are predictive of tumor size and postoperative calcitonin normalization in medullary thyroid carcinoma. Groupe d'Etudes des Tumeurs a Calcitonine (GETC). | Q40776760 | ||
The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis | Q40920116 | ||
Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems | Q41722801 | ||
Relation of doubling time of plasma calcitonin levels to prognosis and recurrence of medullary thyroid carcinoma | Q42461766 | ||
Improved prediction of calcitonin normalization in medullary thyroid carcinoma patients by quantitative lymph node analysis | Q42486469 | ||
Improved diagnostic methods in the follow-up of medullary thyroid carcinoma by highly specific calcitonin measurements | Q42488900 | ||
Calcitonin gene-related peptide in patients with endocrine tumors | Q43617448 | ||
V804M RET mutation and familial medullary thyroid carcinoma: report of a large family with expression of the disease only in the homozygous gene carriers | Q43999293 | ||
Mutational analysis of the RET proto-oncogene in 71 Japanese patients with medullary thyroid carcinoma | Q47989213 | ||
Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. | Q48114164 | ||
Partial nucleotide sequence of human calcitonin precursor mRNA identifies flanking cryptic peptides | Q48406076 | ||
Medullary thyroid carcinoma: clinical features and long-term follow-up of seventy-eight patients treated between 1969 and 1986. | Q50875910 | ||
Medullary carcinoma of the thyroid: prognostic factors and treatment recommendations. | Q50899149 | ||
Multivariate analysis of patients with medullary thyroid carcinoma. Prognostic significance and impact on treatment of clinical and pathologic variables. | Q51035989 | ||
PDN-21: possible tumor marker for medullary thyroid carcinoma. | Q53801229 | ||
Risk and penetrance of primary hyperparathyroidism in multiple endocrine neoplasia type 2A families with mutations at codon 634 of the RET proto-oncogene. Groupe D'etude des Tumeurs à Calcitonine. | Q54435233 | ||
A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma | Q55670928 | ||
Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC | Q57591365 | ||
Calcitonin gene-related peptide as a tumor marker for medullary thyroid carcinoma | Q67906753 | ||
Immunohistochemical study of medullary thyroid carcinoma: relationship of clinical features to prognostic factors in 36 patients | Q70212686 | ||
Relationship of tissue carcinoembryonic antigen and calcitonin to tumor virulence in medullary thyroid carcinoma. An immunohistochemical study in early, localized, and virulent disseminated stages of disease | Q70367447 | ||
Medullary carcinoma of the thyroid. A study of the clinical features and prognostic factors in 161 patients | Q70681913 | ||
Mutations of the ret protooncogene in German multiple endocrine neoplasia families: relation between genotype and phenotype. German Medullary Thyroid Carcinoma Study Group | Q71070755 | ||
Germline mutations of the RET proto-oncogene in eight Japanese patients with multiple endocrine neoplasia type 2A (MEN2A) | Q72555208 | ||
Measurement of serum PDN-21 (Katacalcin) levels by radioimmunoassay in patients with various thyroid diseases | Q72572485 | ||
Novel germline RET proto-oncogene mutations associated with medullary thyroid carcinoma (MTC): mutation analysis in Japanese patients with MTC | Q73511419 | ||
RET proto-oncogene mutation analysis for multiple endocrine neoplasia, type 2 | Q74689538 | ||
Does the syndrome of familial medullary thyroid carcinoma describe a distinct clinical entity? | Q77809229 | ||
Prognosis of a family with familial medullary thyroid carcinoma | Q78178864 | ||
Current status of inherited medullary thyroid carcinoma in Japan | Q84145294 | ||
P433 | issue | 2 | |
P921 | main subject | multiple endocrine neoplasia | Q1553018 |
thyroid carcinoma | Q18556131 | ||
P304 | page(s) | 123-131 | |
P577 | publication date | 2003-01-01 | |
P1433 | published in | Endocrine Pathology | Q15757049 |
P1476 | title | Medullary thyroid carcinoma and multiple endocrine neoplasia type 2. | |
P478 | volume | 14 |